Navigation Links
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Date:3/20/2008

ding that we may not receive necessary regulatory approvals to market our RenalGuard product or that such approvals may be withdrawn, the clinical trials for that product may not be successful, the RenalGuard product may not be commercially accepted, operational changes, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, and additional risk factors described in our Report on Form 10-Q for the quarter ended September 30, 2007, and our other SEC reports.

PLC Systems, PLC Medical Systems, PLC and CO2 Heart Laser, RenalGuard, RenalGuard Therapy and RenalGuard System are trademarks of PLC Systems Inc.

Contact: Mary T. Conway

Conway Communications

617-244-9682

mtconway@att.net


'/>"/>
SOURCE PLC Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
2. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
3. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
4. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
8. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
9. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
10. PLC Systems Reports Fourth Quarter 2007 Results
11. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 Fujirebio Diagnostics Inc., a ... of the Year by the Eastern Technology Council ... Hotel in Philadelphia on Thursday, December 3, 2009. ... the Philadelphia region,s largest technology and life sciences ... the Technology and Life Sciences Community, the awards ...
(Date:12/14/2009)... Dec. 14 Following is a statement ... Consumer Healthcare Products Association (CHPA), regarding today,s release ... Monitoring the Future survey: ,, "Findings released today ... to the need for continued efforts to educate ... to talk to their teens about medicine abuse. ...
(Date:12/14/2009)... Cardinal Health today announced that executives of the company ... Goldman Sachs CEO Unplugged Conference on Jan. ... Center in New York. 28th Annual J.P. ... EST at the Westin St. Francis Hotel in San ... discuss Cardinal Health,s diverse products and services, company performance ...
Breaking Medicine Technology:Fujirebio Diagnostics Named Life Sciences Company of the Year 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Cardinal Health Executives to Speak at Two Investor Events in January 2Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 63155 1Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 63155 2Targeted therapy prolongs life in patients with HER2 positive breast cancer 63152 1Targeted therapy prolongs life in patients with HER2 positive breast cancer 63152 2New Hope for Brain Spinal Cord Injuries 63150 1New Hope for Brain Spinal Cord Injuries 63150 2
... 12, 2007--Inflazyme,Pharmaceuticals Ltd. (TSX: IZP). As announced ... the Phase 2b CAPSICS study with,IPL512,602 showed ... received drug or placebo. However, the placebo,response ... number of,the end-points, which prompted an examination ...
... at,the Stanford University School of Medicine say they ... that an antidepressant,which previously showed promise in treating ... result in a sustained benefit,for the patients who ... prescribed,antidepressant sold under the brand name Lexapro. In ...
Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3
(Date:12/15/2009)... to announce the release of a new report titled, “Incontinence ... for clinical devices used to treat and manage urinary incontinence. ... ... 15, 2009 -- Marketstrat is pleased to announce the release ... The report specifically addresses world markets for clinical devices used ...
(Date:12/15/2009)... study in the Dec. 15 issue of the ... overweight or obese increases the risk for developing obstructive ... children. , Results indicate that the risk ... and older increased 3.5 fold with each standard-deviation increase ... of OSA did not significantly increase with increasing BMI ...
(Date:12/15/2009)... 2009 UT Southwestern Medical Center researchers have ... the unique observable characteristics seen in patients with ... findings, reported online and in the December issue ... Metabolism, suggest that patients with atypical progeroid ... those diagnosed with two similar but more well-defined ...
(Date:12/14/2009)... Dec. 15 In today,s academic medical ... than ever. Now the University HealthSystem Consortium (UHC) ... Value Analysis: Achieving Cost Efficiencies in Health Care, ... complex environments. These new materials, developed with the ... provide a practical guide to planning, implementing, and ...
(Date:12/14/2009)... and NaturalFill™ revolutionary new liposuction and fat transfer treatments can ... all in one minimally invasive treatment. , ... ... AQUALIPO™ and NaturalFill™ can remove excess fat from the abdomen ... people slim down, reduce facial wrinkling and enhance lips all ...
Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Researchers ID traits of people with rare accelerated aging syndrome 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3
... Researchers at the Saint Louis University Institute for Molecular Virology ... cells with HIV virus. ,This discovery will open new doors ... the world. ,It is said that the HIV ... ,One is the Reverse Transcriptase. Secondly it is the Integrase ...
... City Department of Health and Mental Hygiene (DOHMH) has banned ... containing "dangerous levels" of lead and mercury. // , ... Nutrition Board of the Institute of Medicine of the National ... 2 ppm (parts per million) of lead and no more ...
... have successfully operated on 15-month-old twins Mohamed and Souleymane, who ... the first operation of its kind in France. // ... in the steps of similar operations in Britain, South Africa ... division of the La Timone hospital said that at the ...
... by Dr Michael Fenech studied the damage of excess alcohol on ... excess intake of // alcoholic beverages resulted in increased risk of ... the study, six men aged 21-26 stuck to a diet low ... of either complete red wine, red wine with the alcohol removed ...
... genetic link has been discovered by the University of ... this study have been published by the Journal of ... that obese people are prone to develop asthma. The ... between the two conditions. ,The researchers ...
... Vietnamese patients who were infected with the H5N1 bird flu ... Roche drug, Tamiflu. The virus appears to have developed a ... among medical circles. The virus was seen to mutate in ... 274Y resistant strains were seen in both cases. ...
Other Medicine News:Health News:NY Health Dept Bans 3 Ayurveda Drugs 2
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: